This inventor holds 10 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1976-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Takarazuka, JA (1976 - 1978)
- Takarazuka, JP (1980 - 1990)
Company Filing History:
Years Active: 1976-1990
Title: The Innovative Contributions of Yoshihisa Saito
Introduction
Yoshihisa Saito is a prominent inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 10 patents to his name, Saito's work has had a considerable impact on medical science.
Latest Patents
Among his latest patents, Saito has developed disulfide substituted oxazetidine derivatives. This process involves producing a 2-cephem or 3-cephem derivative compound, where R₁ represents a substituted or unsubstituted amino radical, and R₄ can be hydrogen or various radicals. Another notable patent includes new antimicrobial azetidinone derivatives and their salts, which feature R₁ as amino or acylamino, with A selected from a variety of groups.
Career Highlights
Yoshihisa Saito is currently associated with Fujisawa Pharmaceutical Company, Ltd. His work at this esteemed organization has allowed him to focus on innovative pharmaceutical solutions. His research has contributed to advancements in antimicrobial agents and other therapeutic compounds.
Collaborations
Saito has collaborated with notable colleagues such as Takashi Kamiya and Teruo Kyoto Oku. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical innovations.
Conclusion
Yoshihisa Saito's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
